Literature DB >> 27144806

Serum myostatin in central south Chinese postmenopausal women: Relationship with body composition, lipids and bone mineral density.

Yulin Ma1, Xianping Li2, Hongbin Zhang3, Yangna Ou4, Zhimin Zhang3, Shuang Li3, Feng Wu3, Zhifeng Sheng3, Eryuan Liao3.   

Abstract

AIMS: Previous data suggest that myostatin has direct effects on the proliferation and differentiation of osteoprogenitor cells. The relationships between serum myostatin, body composition lipids and bone mineral density in postmenopausal women remain unclear. The aim of this study is to elucidate the relationships between serum myostatin, body composition, lipids and bone mineral density in central south Chinese postmenopausal women.
METHODS: A cross-sectional study was conducted in 175 healthy postmenopausal women, aged 51-75 years old. Bone mineral density (BMD) and body composition were measured by double energy X-ray absorptiometry (DXA). Serum myostatin, 25-dihydroxyvitamin D(25OH-D), parathyroid hormone (PTH), bone alkaline phosphatase (BAP) and carboxy-terminal telopeptide of type I collagen (CTX) were measured by enzyme-linked immunoabsorbent assay (ELISA).
RESULTS: In contrast to the osteoporotic women, the women without osteoporosis had higher BMI, fat mass and lean mass (P<0.01). The osteoporotic women were older than women without osteoporosis (P<0.01). There were no differences between two groups with regard to serum BAP, CTX, (25OH-D), PTH, lipids and myostatin after adjusted by age. BMD at each site was positively correlated with age at menopause, fat mass and lean mass, and also negatively correlated with age and serum BAP. Serum myostatin was positively correlated with tryglicerides, not correlated with either body composition or BMD at each site.
CONCLUSIONS: Our data indicated that serum myostatin concentration did not correlate with muscle and bone mass. Further studies are needed to demonstrate the role of myostatin in regulating the bone metabolism.

Entities:  

Keywords:  Body composition; bone mineral density; myostatin; postmenopausal women

Mesh:

Substances:

Year:  2016        PMID: 27144806     DOI: 10.3109/07435800.2015.1044609

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  5 in total

Review 1.  Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity.

Authors:  Xiaoling Zheng; Yongquan Zheng; Dongxu Qin; Yao Yao; Xiao Zhang; Yunchun Zhao; Caihong Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

2.  Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism.

Authors:  Laurent Maïmoun; Thibault Mura; Vincent Attalin; Anne Marie Dupuy; Jean-Paul Cristol; Antoine Avignon; Denis Mariano-Goulart; Ariane Sultan
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

3.  Association between myostatin serum concentration and body fat level in peri- and postmenopausal women.

Authors:  Iwona Bojar; Radosław Mlak; Iwona Homa-Mlak; Monika Prendecka; Alfred Owoc; Teresa Małecka-Massalska
Journal:  Arch Med Sci       Date:  2021-03-19       Impact factor: 3.318

4.  Relative abundance of mature myostatin rather than total myostatin is negatively associated with bone mineral density in Chinese.

Authors:  Long-Fei Wu; Dong-Cheng Zhu; Bing-Hua Wang; Yi-Hua Lu; Pei He; Yun-Hong Zhang; Hong-Qin Gao; Xiao-Wei Zhu; Wei Xia; Hong Zhu; Xing-Bo Mo; Xin Lu; Lei Zhang; Yong-Hong Zhang; Fei-Yan Deng; Shu-Feng Lei
Journal:  J Cell Mol Med       Date:  2017-12-16       Impact factor: 5.310

5.  Association Between Bone Mineral Density and Lipid Profile in Chinese Women.

Authors:  Qi Zhang; Junteng Zhou; Qin Wang; Chunyan Lu; Yong Xu; Hongyi Cao; Xiaohua Xie; Xueyan Wu; Jing Li; Decai Chen
Journal:  Clin Interv Aging       Date:  2020-09-15       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.